B
BioXcel Therapeutics, Inc. Common StockBTAI
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company built on artificial intelligence ('AI') to develop transformative medicines in neuroscience. Its wholly owned subsidiary, OnkosXcel Therapeutics, is focused on the development of medicines in.
US StocksHealthcareSmall CapArtificial IntelligenceBiotechnologyGrowth Stocks
BTAI Price Trend
BioXcel Therapeutics, Inc. Common Stock · Full TradingView Chart
NASDAQ:BTAI